‘Why we run’ – hear from Providence’s Hood To Coast teams
“For my patients.” “For my friend’s daughter.” “For the challenge.” “For the cure.” Providence runners and walkers share why they’re doing the relay – and helping raise funds to #FINISHCANCER.
Read Article
Dr. Walter Urba announces retirement from Providence
Dr. Walter Urba, a pioneer and key figure in the development of immunotherapy, will retire from Providence Cancer Institute at the end of year.
Read Article
Dr. Bernard Fox honored for his lifetime contributions to cancer research
Prominent cancer scientist Dr. Bernard Fox recognized for his work to advance the field of cancer immunotherapy through increasing public understanding, awareness and research efforts.
Read Article
Can these new studies offer hope for people with lung and head and neck cancers?
A new medication may help people with KRAS G12C-mutant non-small cell lung cancer. Read about the study and a trial evaluating an immunotherapy for treating head and neck squamous cell carcinoma.
Read Article
Cancer survivor speaks with doctor he credits for saving his life
Cancer survivor Mark Williams chats with Dr. Brendan Curti about
Read Article
2024 Hood to Coast Relay: Providence team captains tell us why they run
What motivates the co-captains of the FINISHCANCER caregiver team to commit their time to running this remarkable relay? Read what they say about preparing for the race and what inspires them to run.
Read Article
Promising advances in treating TNBC: Two studies offer hope
Although chemotherapy is the cornerstone treatment for triple negative breast cancer, survival outcomes remain disappointing. Two studies could help improve treatment options.
Read Article
Providence notifies patients of recommended testing
Read Article
See stories of hope in annual report to our communities
In 2023, Providence in Oregon did so much to make sure that essential resources – such as health care, food and shelter – were more readily available to the people of our state.
Read Article
Targeting cancer cells: Two studies take different approaches
A study designed to treat recurrent epithelial ovarian cancer looks at an antibody drug conjugate, and a second study for people with advanced breast cancer evaluates a drug that degrades estrogen rec
Read Article
K-9 team brings smiles and safety to Providence Portland
Walk in the shoes of security officer Patricia Varela and her K-9 partner Nix, and experience their important work to keep everyone safe at Providence Portland Medical Center.
Read Article
The evolution of cancer immunotherapy: Dr. Urba shares his insights
Providence Cancer Institute chief medical officer Walter J. Urba, M.D., Ph.D. talks about the evolution of immunotherapy in the past three decades and his vision for its future.
Read Article
Welcome back
This morning, six Providence hospitals in Oregon welcomed our nurses back as we began working together again.
Read Article
3 things to know about getting care during the ONA strikes
Here's what to know about getting care at Providence hospitals during the Oregon Nurses Association strike.
Read Article
Cancer survivorship: A guide to living with and beyond cancer
June is National Cancer Survivor Month, but we honor people with cancer, no matter where they are on their journey, every day of the year. Find out about the survivorship program at Providence Cancer
Read Article
Radiation oncologist discusses MRI-guided radiation therapy for pancreatic cancer
Providence Cancer Institute presented a free virtual education event about MRI-guided radiation therapy and how it is used to treat pancreatic cancer.
Read Article
Providence researchers contribute study findings at ASCO 2024 meeting, May 31- June 3
The annual meeting of cancer experts is a platform to collaborate and accelerate cancer research findings into clinical applications.
Read Article
With the potential to transform cancer diagnostics, Providence contributes to innovative AI-powered digital pathology model
A joint study between Providence, Microsoft and the University of Washington detailing work to create a novel AI-powered pathology model has been published in Nature.
Read Article
Cancer studies seek to harness the power of the immune system
Explore three innovative studies targeting uveal melanoma, melanoma and head and neck squamous cell carcinoma. Learn why these studies offer hope for more effective cancer treatments.
Read Article
Providence Oregon hospitals earn national recognition for environmental stewardship work
Practice Greenhealth recognizes Providence’s commitment to environmental stewardship, names Providence a ‘System of Change’
Read Article